121 related articles for article (PubMed ID: 9269032)
1. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients.
Toyoda M; Galfayan K; Galera OA; Petrosian A; Czer LS; Jordan SC
Transpl Immunol; 1997 Jun; 5(2):104-11. PubMed ID: 9269032
[TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection.
Toyoda M; Petrosian A; Jordan SC
Transplantation; 1999 Nov; 68(9):1311-8. PubMed ID: 10573069
[TBL] [Abstract][Full Text] [Related]
3. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation.
Fredrich R; Toyoda M; Czer LS; Galfayan K; Galera O; Trento A; Freimark D; Young S; Jordan SC
Transplantation; 1999 Feb; 67(3):385-91. PubMed ID: 10030283
[TBL] [Abstract][Full Text] [Related]
5. Analysis of chemokines and soluble adhesion molecules in cytomegalovirus-positive renal transplant recipients.
Obeid OE; Alzahrani AJ
J Infect Dev Ctries; 2010 Mar; 4(2):110-3. PubMed ID: 20212343
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection.
Han F; Lv R; Jin J; Wu J; Chen Y; Wang H; Chen J
Clin Chem Lab Med; 2009; 47(10):1265-9. PubMed ID: 19751142
[TBL] [Abstract][Full Text] [Related]
7. Non-organ-specific and anti-endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients.
Costa C; Touscoz GA; Bergallo M; Terlizzi ME; Astegiano S; Sidoti F; Sinesi F; Segoloni GP; Cavallo R
Clin Transplant; 2010; 24(4):488-92. PubMed ID: 19758268
[TBL] [Abstract][Full Text] [Related]
8. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection.
Ferry BL; Welsh KI; Dunn MJ; Law D; Proctor J; Chapel H; Yacoub MH; Rose ML
Transpl Immunol; 1997 Mar; 5(1):17-24. PubMed ID: 9106330
[TBL] [Abstract][Full Text] [Related]
9. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
Basson J; Tardy JC; Aymard M
Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies.
Guo X; Hu J; Luo W; Luo Q; Guo J; Tian F; Ming Y; Zou Y
J Immunol Res; 2017; 2017():8679841. PubMed ID: 28265584
[TBL] [Abstract][Full Text] [Related]
11. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
Taherimahmoudi M; Ahmadi H; Baradaran N; Montaser-Kouhsari L; Salem S; Mehrsai A; Kalantar E; Jahani Y; Pourmand G
Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452
[TBL] [Abstract][Full Text] [Related]
13. Detection of cytomegalovirus infections by PCR in renal transplant patients.
Costa SC; Miranda SR; Alves G; Rossi CL; Figueiredo LT; Costa FF
Braz J Med Biol Res; 1999 Aug; 32(8):953-9. PubMed ID: 10454756
[TBL] [Abstract][Full Text] [Related]
14. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
[TBL] [Abstract][Full Text] [Related]
16. Does pre-transplant in vitro detection of anti-endothelial cell antibodies predict renal allograft outcome?
Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
Egypt J Immunol; 2008; 15(1):115-22. PubMed ID: 20306676
[TBL] [Abstract][Full Text] [Related]
17. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
18. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia.
Varani S; Muratori L; De Ruvo N; Vivarelli M; Lazzarotto T; Gabrielli L; Bianchi FB; Bellusci R; Landini MP
J Med Virol; 2002 Jan; 66(1):56-62. PubMed ID: 11748659
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
